Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R8XX
|
||||
Former ID |
DNC007892
|
||||
Drug Name |
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]lauramide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529162] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H34N2O2
|
||||
Canonical SMILES |
CCCCCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O
|
||||
InChI |
1S/C22H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-22(26)23-15-14-18-17-24-21-13-12-19(25)16-20(18)21/h12-13,16-17,24-25H,2-11,14-15H2,1H3,(H,23,26)
|
||||
InChIKey |
MOQBGJJXYJJJFQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529162] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.